Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bf1688d530f976283d265590d5fa6235e> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bf1688d530f976283d265590d5fa6235e NCIT_P378 "NCI" @default.
- Bf1688d530f976283d265590d5fa6235e type Axiom @default.
- Bf1688d530f976283d265590d5fa6235e annotatedProperty IAO_0000115 @default.
- Bf1688d530f976283d265590d5fa6235e annotatedSource NCIT_C160116 @default.
- Bf1688d530f976283d265590d5fa6235e annotatedTarget "A regimen consisting of ruxolitinib that may be used in the treatment of myeloproliferative neoplasms, atypical chronic myeloid leukemia (aCML) with CSF3R or JAK2 mutation, and myeloid or lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes involving JAK2 rearrangement." @default.